Octreotide LAR in neuroendocrine tumors - a summary of the experience

Neuroendocrine tumors are a rare and heterogeneous group of neoplasms. Most of the patient is diagnosed with locally advanced or metastatic disease and curative surgery is rarely an option. Somatostatin analogues have b...

Adjuvant imatinib after resection of gastrointestinal stromal tumour - systematic review and meta-analysis

[b]Background:[/b] Adjuvant therapy is recommended for population of patients with high risk of recurrence after resection of gastrointestinal stromal tumour.[b]The aim of the study:[/b] Evaluation of clinical efficacy a...

Childhood Cancer Survivorship Late Cardiotoxicity, and CV Prevention

Nefrotoksyczność leków stosowanych w chemioterapii nowotworów

Rozwój onkologii klinicznej oraz coraz częstsza zapadalność na nowotwory powodują szybkie zwiększanie się grupy chorych leczonych chemioterapeutykami. Stosowanie tych leków oprócz korzyści niesie ze sobą również ryzyko w...

New data concerning treatment of urogenital cancer patients presented at annual congress of American Society of Clinical Oncology 2011

INTRODUCTION: The annual congress of The American Society of Clinical Oncology took place between 03.06.2011 and 06.06.2011 in Chicago, the US.MATERIAL AND METHODS: Papers presented during ASCO are discussed in four sect...